Skip to content

Biogen

NASDAQ: BIIB · USD

Biogen cash flow and EPS—

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$40.9M
Biogen capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q2UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FY 2009 Q361.21% · $181.85M0% · $0M38.79% · $115.262MUnavailableUnavailable100% · $297.112M
FY 2009 Q47.41% · $55.517M0% · $0M92.59% · $693.539MUnavailableUnavailable100% · $749.056M
FY 2010 Q15.83% · $38.209M6.1% · $39.976M88.08% · $577.58MUnavailableUnavailable100% · $655.765M
FY 2010 Q24.36% · $47.051M0% · $0M95.64% · $1,031.754MUnavailableUnavailable100% · $1,078.805M
FY 2010 Q37.68% · $38.96M0% · $0M92.32% · $468.245MUnavailableUnavailable100% · $507.205M
FY 2010 Q460.04% · $48.835M39.96% · $32.5M0% · $0MUnavailableUnavailable100% · $81.335M
FY 2011 Q114.13% · $32.143MUnavailable85.87% · $195.287MUnavailableUnavailable100% · $227.43M
FY 2011 Q222.04% · $54.086MUnavailable77.96% · $191.288MUnavailableUnavailable100% · $245.374M
FY 2011 Q3100% · $51.349MUnavailable0% · $0MUnavailableUnavailable100% · $51.349M
FY 2011 Q437.7% · $70.442M2.68% · $5M59.62% · $111.4MUnavailableUnavailable100% · $186.842M
FY 2012 Q19.24% · $54.551M12.27% · $72.401M78.49% · $463.171MUnavailable0% · $0M100% · $590.123M
FY 2012 Q214.03% · $72.896M0% · $0M85.97% · $446.78MUnavailable0% · $0M100% · $519.676M
FY 2012 Q352.18% · $58.064M0% · $0M47.82% · $53.22MUnavailable0% · $0M100% · $111.284M
FY 2012 Q474.23% · $69.037M0% · $0M23.16% · $21.544MUnavailable2.61% · $2.428M100% · $93.009M
FY 2013 Q16.35% · $33.289M0% · $0M7.82% · $41.023MUnavailable85.83% · $450M100% · $524.312M
FY 2013 Q295.86% · $54.151M0% · $0M0% · $0MUnavailable4.14% · $2.34M100% · $56.491M
FY 2013 Q3100% · $80.188M0% · $0MUnavailableUnavailable0% · $0M100% · $80.188M
FY 2013 Q483.98% · $78.653M16.02% · $15M0% · $0.001MUnavailable0% · $0M100% · $93.654M
FY 2014 Q168.48% · $54.306M31.52% · $25M0% · $0MUnavailable0% · $0M100% · $79.306M
FY 2014 Q215.96% · $64.002M0% · $0M84.04% · $336.905MUnavailable0% · $0M100% · $400.907M
FY 2014 Q326.25% · $62.546M62.95% · $150M9.68% · $23.076MUnavailable1.12% · $2.674M100% · $238.296M
FY 2014 Q416.87% · $106.897MUnavailable83.13% · $526.798MUnavailable0% · $0M100% · $633.695M
FY 2015 Q132.98% · $97.83M67.02% · $198.798MUnavailableUnavailableUnavailable100% · $296.628M
FY 2015 Q2100% · $129.858M0% · $0MUnavailableUnavailableUnavailable100% · $129.858M
FY 2015 Q37.2% · $229.197M0% · $0M92.8% · $2,955.997MUnavailableUnavailable100% · $3,185.194M
FY 2015 Q48.51% · $186.115M0% · $0.002M91.49% · $2,001.81MUnavailableUnavailable100% · $2,187.927M
FY 2016 Q1100% · $126.9M0% · $0M0% · $0MUnavailableUnavailable100% · $126.9M
FY 2016 Q2100% · $136.8M0% · $0M0% · $0MUnavailableUnavailable100% · $136.8M
FY 2016 Q332.8% · $170.3M0% · $0M67.2% · $348.9MUnavailableUnavailable100% · $519.2M
FY 2016 Q421.86% · $182.1M0% · $0M78.14% · $651.1MUnavailableUnavailable100% · $833.2M
FY 2017 Q126.46% · $210MUnavailable73.54% · $583.6MUnavailableUnavailable100% · $793.6M
FY 2017 Q220.18% · $197.7MUnavailable79.82% · $781.8MUnavailableUnavailable100% · $979.5M
FY 2017 Q3100% · $229.1MUnavailable0% · $0MUnavailableUnavailable100% · $229.1M
FY 2017 Q4100% · $230.6MUnavailable0% · $0MUnavailableUnavailable100% · $230.6M
FY 2018 Q143.78% · $194.7MUnavailable56.22% · $250MUnavailableUnavailable100% · $444.7M
FY 2018 Q26.36% · $186.8MUnavailable93.64% · $2,750MUnavailableUnavailable100% · $2,936.8M
FY 2018 Q3100% · $163.2M0% · $0M0% · $0MUnavailableUnavailable100% · $163.2M
FY 2018 Q414.31% · $225.9M0% · $0M85.69% · $1,352.6MUnavailableUnavailable100% · $1,578.5M
FY 2019 Q116.23% · $127.1MUnavailable83.77% · $655.8MUnavailableUnavailable100% · $782.9M
FY 2019 Q27.22% · $186.9MUnavailable92.78% · $2,401.5MUnavailableUnavailable100% · $2,588.4M
FY 2019 Q311.15% · $90.1M0% · $0M88.85% · $717.9MUnavailable0% · $0M100% · $808M
FY 2019 Q45.01% · $110.4M0% · $0M94.99% · $2,093.1MUnavailableUnavailable100% · $2,203.5M
FY 2020 Q16.32% · $149.7MUnavailable93.68% · $2,220.2MUnavailable0% · $0M100% · $2,369.9M
FY 2020 Q23.6% · $105MUnavailable96.4% · $2,808.9MUnavailable0% · $0M100% · $2,913.9M
FY 2020 Q36.3% · $84.1MUnavailable93.7% · $1,250MUnavailable0% · $0M100% · $1,334.1M
FY 2020 Q44.33% · $86MUnavailable20.14% · $400MUnavailable75.53% · $1,500M100% · $1,986M
FY 2021 Q110.74% · $92.6MUnavailable69.61% · $600MUnavailable19.64% · $169.3M100% · $861.9M
FY 2021 Q213.76% · $71.9MUnavailable86.11% · $450MUnavailable0.13% · $0.7M100% · $522.6M
FY 2021 Q35.3% · $42MUnavailable94.7% · $750MUnavailable0% · $0M100% · $792M
FY 2021 Q4100% · $51.6MUnavailable0% · $0MUnavailableUnavailable100% · $51.6M
FY 2022 Q16.87% · $36.9MUnavailable93.13% · $500MUnavailable0% · $0M100% · $536.9M
FY 2022 Q34.51% · $59.1MUnavailable19.07% · $250MUnavailable76.43% · $1,002.2M100% · $1,311.3M
FY 2022 Q4100% · $86.4MUnavailable0% · $0MUnavailableUnavailable100% · $86.4M
FY 2023 Q1100% · $66.6MUnavailableUnavailableUnavailable0% · $0M100% · $66.6M
FY 2023 Q2100% · $71MUnavailableUnavailableUnavailable0% · $0M100% · $71M
FY 2023 Q331.7% · $74.2MUnavailable0% · $0MUnavailable68.3% · $159.9M100% · $234.1M
FY 2023 Q44.99% · $65.2M45.22% · $590.5M0% · $0MUnavailable49.78% · $650M100% · $1,305.7M
FY 2024 Q110.29% · $45.9MUnavailableUnavailableUnavailable89.71% · $400M100% · $445.9M
FY 2024 Q211.82% · $33.5MUnavailableUnavailableUnavailable88.18% · $250M100% · $283.5M
FY 2024 Q3100% · $35MUnavailableUnavailableUnavailable0% · $0M100% · $35M
FY 2024 Q4100% · $39.3M0% · $0MUnavailableUnavailable0% · $0M100% · $39.3M
FY 2025 Q1100% · $37.1MUnavailableUnavailableUnavailable0% · $0M100% · $37.1M
FY 2025 Q21.5% · $26.6MUnavailableUnavailableUnavailable98.5% · $1,750M100% · $1,776.6M
FY 2025 Q3100% · $46.2MUnavailableUnavailableUnavailable0% · $0M100% · $46.2M
FY 2025 Q4100% · $43.9MUnavailableUnavailableUnavailable0% · $0M100% · $43.9M
FY 2026 Q1100% · $51.2MUnavailableUnavailableUnavailableUnavailable100% · $51.2M
FY 2026 Q2100% · $40.9MUnavailableUnavailableUnavailableUnavailable100% · $40.9M
Jun 30, 2009 through Jun 30, 2026

Operating cash flow

USD millions

$448.9M

Capital expenditures

USD millions

$40.9M

Free cash flow

USD millions

$408M

Stock-based compensation

USD millions

$77.4M

SBC / free cash flow

% · FCF before SBC deduction

18.97%

SBC / operating cash flow

%

17.24%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$0.66

Quarterly data

Biogen cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 2026448.940.940877.418.97%17.24%—$0.66
FY 2026 Q1Mar 31, 2026645.551.2594.38414.13%13.01%—$2.15
FY 2025 Q4Dec 31, 2025511.943.946859.612.74%11.64%——
FY 2025 Q3Sep 30, 20251,272.546.21,226.375.36.14%5.92%—$3.17
FY 2025 Q2Jun 30, 2025160.926.6134.374.955.77%46.55%—$4.33
FY 2025 Q1Mar 31, 2025259.337.1222.28136.45%31.24%—$1.64
FY 2024 Q4Dec 31, 2024760.939.3721.675.110.41%9.87%——
FY 2024 Q3Sep 30, 2024935.635900.672.78.07%7.77%—$2.66
FY 2024 Q2Jun 30, 2024625.833.5592.370.611.92%11.28%—$4
FY 2024 Q1Mar 31, 2024553.245.9507.372.814.35%13.16%—$2.7
FY 2023 Q4Dec 31, 202312.565.2-52.754.9—439.2%——
FY 2023 Q3Sep 30, 2023592.474.2518.262.212%10.5%—$-0.47
FY 2023 Q2Jun 30, 20234877141671.517.19%14.68%—$4.07
FY 2023 Q1Mar 31, 2023455.366.6388.775.619.45%16.6%—$2.67
FY 2022 Q4Dec 31, 2022-17586.4-261.467.2————
FY 2022 Q3Sep 30, 202266159.1601.963.610.57%9.62%—$7.84
FY 2022 Q1Jun 30, 2022736.536.9699.655.77.96%7.56%—$7.24
FY 2021 Q4Dec 31, 2021838.351.6786.758.87.47%7.01%——
FY 2021 Q3Sep 30, 2021805.342763.355.77.3%6.92%—$2.22
FY 2021 Q2Jun 30, 20211,227.371.91,155.454.14.68%4.41%—$2.99
FY 2021 Q1Mar 31, 202176992.6676.47010.35%9.1%—$2.69
FY 2020 Q4Dec 31, 2020-367.186-453.149———$2.32
FY 2020 Q3Sep 30, 20201,181.184.11,09733.53.05%2.84%—$4.46
FY 2020 Q2Jun 30, 20201,948.51051,843.548.12.61%2.47%—$9.59
FY 2020 Q1Mar 31, 20201,467.3149.71,317.667.75.14%4.61%—$8.08
FY 2019 Q4Dec 31, 20191,960.2110.41,849.838.42.08%1.96%—$8.08
FY 2019 Q3Sep 30, 20191,694.990.11,604.845.92.86%2.71%—$8.39
FY 2019 Q2Jun 30, 20191,964186.91,777.152.32.94%2.66%—$7.85
FY 2019 Q1Mar 31, 20191,459.5127.11,332.445.73.43%3.13%—$7.15
FY 2018 Q4Dec 31, 20181,895.4225.91,669.538.52.31%2.03%—$4.73
FY 2018 Q3Sep 30, 20181,735.9163.21,572.737.32.37%2.15%—$7.15
FY 2018 Q2Jun 30, 20181,099.3186.8912.538.34.2%3.48%—$4.18
FY 2018 Q1Mar 31, 20181,457.1194.71,262.443.43.44%2.98%—$5.54
FY 2017 Q4Dec 31, 20171,518.3230.61,287.730.62.38%2.02%—$-1.4
FY 2017 Q3Sep 30, 20171,628.3229.11,399.230.12.15%1.85%—$5.79
FY 2017 Q2Jun 30, 20171,169.2197.7971.530.33.12%2.59%—$4.07
FY 2017 Q1Mar 31, 2017235.221025.237146.83%15.73%—$3.46
FY 2016 Q4Dec 31, 20161,576.6182.11,394.5372.65%2.35%—$2.99
FY 2016 Q3Sep 30, 2016986.6170.3816.333.74.13%3.42%—$4.71
FY 2016 Q2Jun 30, 2016995.8136.885938.84.52%3.9%—$4.79
FY 2016 Q1Mar 31, 2016963.4126.9836.545.35.42%4.7%—$4.43
FY 2015 Q4Dec 31, 20151,040.4186.12854.2829.863.5%2.87%—$3.77
FY 2015 Q3Sep 30, 2015895.45229.2666.2537.865.68%4.23%—$4.15
FY 2015 Q2Jun 30, 20151,047.22129.86917.3641.614.54%3.97%—$3.93
FY 2015 Q1Mar 31, 2015733.0497.83635.2152.068.2%7.1%—$3.49
FY 2014 Q4Dec 31, 2014932.86106.9825.9735.794.33%3.84%—$3.74
FY 2014 Q3Sep 30, 2014914.0362.55851.4935.654.19%3.9%—$3.62
FY 2014 Q2Jun 30, 2014990.5964926.5937.524.05%3.79%—$3.01
FY 2014 Q1Mar 31, 2014104.6354.3150.3246.3492.09%44.29%—$2.02
FY 2013 Q4Dec 31, 2013869.0178.65790.3531.443.98%3.62%—$1.92
FY 2013 Q3Sep 30, 2013671.9280.19591.7337.466.33%5.58%—$2.05
FY 2013 Q2Jun 30, 2013625.2154.15571.0630.635.36%4.9%—$2.06
FY 2013 Q1Mar 31, 2013178.9433.29145.6536.7625.24%20.54%—$1.79
FY 2012 Q4Dec 31, 2012507.9169.04438.8730.196.88%5.94%—$1.23
FY 2012 Q3Sep 30, 2012541.7858.06483.7227.915.77%5.15%—$1.67
FY 2012 Q2Jun 30, 2012635.5872.9562.6928.074.99%4.42%—$1.61
FY 2012 Q1Mar 31, 2012194.6354.55140.0732.423.13%16.65%—$1.25
FY 2011 Q4Dec 31, 2011473.9770.44403.5326.386.54%5.57%—$1.22
FY 2011 Q3Sep 30, 2011570.5251.35519.1729.235.63%5.12%—$1.43
FY 2011 Q2Jun 30, 2011429.6754.09375.5824.286.46%5.65%—$1.18
FY 2011 Q1Mar 31, 2011253.5832.14221.4433.1214.96%13.06%—$1.2
FY 2010 Q4Dec 31, 2010431.0648.84382.2233.238.69%7.71%—$0.99
FY 2010 Q3Sep 30, 2010428.2438.96389.2839.2210.08%9.16%—$1.05
FY 2010 Q2Jun 30, 2010428.4847.05381.4344.3611.63%10.35%—$1.12
FY 2010 Q1Mar 31, 2010336.938.21298.6951.0117.08%15.14%—$0.8
FY 2009 Q4Dec 31, 2009282.1755.52226.664118.09%14.53%—$1.06
FY 2009 Q3Sep 30, 2009263.43181.8581.5841.0150.27%15.57%—$0.95
FY 2009 Q2Jun 30, 2009228.55108.76119.794134.23%17.94%—$0.49
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · BIIB, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.